University of Missouri part of clinical trials for new coronavirus vaccine
The clinical trial is testing the safety and effectiveness of NVX-CoV2373 which was developed by the U.S. biotechnology company Novavax. The trials for the Novavax vaccine involve 30,000 people across approximately 115 sites in the United States and Mexico.
Continue Reading